Claritev
Fernando Schwartz, PhD, currently serves as SVP and Chief AI Officer at Claritev, where Fernando oversees AI initiatives. Previously, Fernando held the position of VP of AI at ADP, leading the development of the OneAI platform and building a team of skilled AI professionals. Prior roles include AVP Global Head of Data Science at Merck, VP Data Science at CitiusTech, and Chief Data Scientist at Prognos, all of which involved establishing and managing teams focused on innovative AI solutions. Fernando's academic background includes a PhD in Mathematics from Cornell University and professorships at institutions such as the University of Tennessee and Duke University, with research interests in artificial intelligence and machine learning.
This person is not in any teams
This person is not in any offices
Claritev
Claritev is an independent and public healthcare technology, data and insights company making healthcare more transparent, fair and affordable for all. We work across the healthcare value chain to expose imbalanced and inefficient pricing practices. Led by deeply experienced analysts, negotiators and innovators, Claritev provides tech-enabled solutions and services fueled by proprietary data from over 40 years of experience. Today, along with machine learning and AI, we utilize a robust enterprise platform to deliver price transparency, improve payment accuracy, and drive more meaningful analytics and decision-making. Through Claritev, providers are able to make data-enabled decisions to optimize their service offerings, market position and ultimately deliver high-quality care. Payors and third-party administrators can deliver greater flexibility and value to plan sponsors. Employers can drive cost-efficient benefit design and patients can finally afford the care they need. By focusing on customized solutions that that improve transparency, affordability and quality for all key players, we’re igniting a more competitive marketplace — one that lowers overall costs while improving quality. Claritev brings the transparency our nation needs to see its way to a better healthcare system.